Go Makimoto

651 total citations
60 papers, 298 citations indexed

About

Go Makimoto is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Go Makimoto has authored 60 papers receiving a total of 298 indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Pulmonary and Respiratory Medicine, 37 papers in Oncology and 11 papers in Molecular Biology. Recurrent topics in Go Makimoto's work include Lung Cancer Treatments and Mutations (29 papers), Lung Cancer Research Studies (11 papers) and Cancer Immunotherapy and Biomarkers (10 papers). Go Makimoto is often cited by papers focused on Lung Cancer Treatments and Mutations (29 papers), Lung Cancer Research Studies (11 papers) and Cancer Immunotherapy and Biomarkers (10 papers). Go Makimoto collaborates with scholars based in Japan, United States and Taiwan. Go Makimoto's co-authors include Katsuyuki Kiura, Katsuyuki Hotta, Yoshinobu Maeda, Kadoaki Ohashi, Toshio Kubo, Eiki Ichihara, Takashi Ninomiya, Hisao Higo, Kiichiro Ninomiya and Masahiro Tabata and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Go Makimoto

52 papers receiving 292 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Go Makimoto Japan	10	193	147	81	34	34	60	298
Anna Klimczak Poland	12	202 1.0×	149 1.0×	64 0.8×	51 1.5×	28 0.8×	32	328
Till Plönes Germany	12	224 1.2×	180 1.2×	85 1.0×	39 1.1×	13 0.4×	53	406
Walid Shalata Israel	11	141 0.7×	224 1.5×	48 0.6×	47 1.4×	29 0.9×	62	388
Norimitsu Kasahara Japan	10	163 0.8×	196 1.3×	40 0.5×	22 0.6×	13 0.4×	29	301
Andrea D. Chapman United Kingdom	10	174 0.9×	162 1.1×	81 1.0×	56 1.6×	23 0.7×	20	361
Rie Nakatsuka Japan	9	71 0.4×	86 0.6×	76 0.9×	65 1.9×	15 0.4×	21	240
Cristiano Lanza Italy	10	87 0.5×	126 0.9×	58 0.7×	85 2.5×	32 0.9×	18	282
A. Qin United States	8	149 0.8×	208 1.4×	32 0.4×	24 0.7×	18 0.5×	20	286
Kakeru Hisakane Japan	10	215 1.1×	179 1.2×	77 1.0×	27 0.8×	10 0.3×	35	336
Chang Hun Lee South Korea	11	230 1.2×	128 0.9×	88 1.1×	68 2.0×	22 0.6×	23	375

Countries citing papers authored by Go Makimoto

Since Specialization

Citations

This map shows the geographic impact of Go Makimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Go Makimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Go Makimoto more than expected).

Fields of papers citing papers by Go Makimoto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Go Makimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Go Makimoto. The network helps show where Go Makimoto may publish in the future.

Co-authorship network of co-authors of Go Makimoto

This figure shows the co-authorship network connecting the top 25 collaborators of Go Makimoto. A scholar is included among the top collaborators of Go Makimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Go Makimoto. Go Makimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nagasaki, Joji, Takamasa Ishino, Youki Ueda, et al.. (2025). Close Spatial Interactions between Cancer Cells and Cancer-Associated Fibroblasts Suppress Antitumor Immunity. Cancer Immunology Research. 13(9). 1471–1484.

Kinoshita, Rie, Kiichiro Ninomiya, Go Makimoto, et al.. (2025). Plasma S100A8/A9 level predicts response to immune checkpoint inhibitors in patients with advanced non-small cell lung cancer. Scientific Reports. 15(1). 2577–2577.

Tomida, Shuta, Naofumi Hara, Hirofumi Inoue, et al.. (2025). Colony-Stimulating Factor-1 Receptor Inhibitor Augments Osimertinib-Induced Antitumor Immunity via Suppression of Macrophages in Lung Cancer Harboring EGFR Mutation. Molecular Cancer Therapeutics. 24(11). 1763–1774.

Tanaka, Takaaki, Go Makimoto, Ryohei Sumii, et al.. (2025). Remarkable Efficacy of Capmatinib in a Patient with Cancer of Unknown Primary with MET Amplification. Internal Medicine. 64(23). 3460–3464.

Nishi, Tatsuya, Ayako Morita, Naofumi Hara, et al.. (2025). Efficacy of amivantamab, a bi-specific antibody targeting EGFR and MET, in ALK-rearranged non-small-cell lung cancer cell lines. Lung Cancer. 201. 108415–108415. 1 indexed citations

Bodor, J. Nicholas, Jonathan E. Dowell, Joseph Treat, et al.. (2025). Phase II Trial of LP-300 in Combination With Carboplatin and Pemetrexed in Never Smoker Patients With Relapsed Advanced Primary Adenocarcinoma of the Lung After Treatment With Tyrosine Kinase Inhibitors. Clinical Lung Cancer. 26(6). 511–514. 1 indexed citations

Makimoto, Go, Takaaki Tanaka, Yuka Kato, et al.. (2024). A randomized, open-label phase II study on the preventive effect of goshajinkigan against peripheral neuropathy induced by paclitaxel-containing chemotherapy: The OLCSG2101 study protocol. Respiratory Investigation. 62(5). 897–900. 1 indexed citations

Ninomiya, Kiichiro, Daisuke Ennishi, Kunio Okamoto, et al.. (2024). Response to Imatinib in a Patient With Gastric Adenocarcinoma With KIT Q556_K558 In-Frame Deletion: A Case Report. JCO Precision Oncology. 8(8). e2400228–e2400228.

Matsuura, Hiroaki, Hisao Higo, Go Makimoto, et al.. (2024). Concomitant osimertinib and antituberculosis therapy in an elderly patient with EGFR‐mutated lung cancer and pulmonary tuberculosis: A case report. Thoracic Cancer. 15(17). 1390–1394. 2 indexed citations

10.

Tanaka, Takaaki, Go Makimoto, Kiichiro Ninomiya, et al.. (2023). Severe Cytokine Release Syndrome and Immune Effector Cell-associated Neurotoxicity Syndrome in a Man Receiving Immune Checkpoint Inhibitors for Lung Cancer. Internal Medicine. 63(9). 1261–1267. 4 indexed citations

11.

Kudo, Kenichiro, Kazuya Nishii, Go Makimoto, et al.. (2022). First and repeat rebiopsy for detecting EGFR T790M mutation in non-small-cell lung cancer: CS-Lung-003 prospective observational registry study. Journal of Cancer Research and Clinical Oncology. 148(8). 1869–1877. 6 indexed citations

12.

Higo, Hisao, Kadoaki Ohashi, Shuta Tomida, et al.. (2022). Identification of targetable kinases in idiopathic pulmonary fibrosis. Respiratory Research. 23(1). 20–20. 9 indexed citations

13.

Makimoto, Go, Mahito Misawa, Yoshinobu Maeda, & Katsuyuki Kiura. (2022). Dasatinib-induced massive left chylothorax in a patient with chronic myeloid leukemia. Respiratory Medicine Case Reports. 37. 101662–101662. 3 indexed citations

14.

Makimoto, Go, Kiichiro Ninomiya, Hisao Higo, et al.. (2022). Massive hemoptysis in a post-operative patient with recurrent lung cancer successfully treated by the combination therapy of Endobronchial Watanabe Spigot and bronchial artery embolization. Respiratory Medicine Case Reports. 38. 101669–101669. 1 indexed citations

15.

Makimoto, Go, Kadoaki Ohashi, Kiichiro Ninomiya, et al.. (2022). Successful and Prompt Treatment with Tepotinib for Lung Adenocarcinoma Harboring MET Exon 14 Skipping Mutation Combined with Lung Abscess Formation: A Case Report. SHILAP Revista de lepidopterología. 15(2). 494–498. 2 indexed citations

16.

Makimoto, Go, et al.. (2021). Successful corticosteroid treatment of necrotizing sarcoid granulomatosis associated with tracheal lesion recurred after a surgical lung biopsy. Respiratory Medicine Case Reports. 33. 101402–101402. 1 indexed citations

17.

Higo, Hisao, Kadoaki Ohashi, Go Makimoto, et al.. (2019). EGFR-TKI acquired resistance in lung cancers harboring EGFR mutations in immunocompetent C57BL/6J mice. Lung Cancer. 136. 86–93. 5 indexed citations

18.

Tamura, Tomoki, Yuka Kato, Kadoaki Ohashi, et al.. (2017). Potential influence of interleukin-6 on the therapeutic effect of gefitinib in patients with advanced non-small cell lung cancer harbouring EGFR mutations. Biochemical and Biophysical Research Communications. 495(1). 360–367. 15 indexed citations

19.

Makimoto, Go, Keiichi Fujiwara, Hiromi Watanabe, et al.. (2014). nab-Paclitaxel in Combination with Carboplatin for a Previously Treated Thymic Carcinoma. Case Reports in Oncology. 7(1). 14–17. 9 indexed citations

20.

Makimoto, Go, Keiichi Fujiwara, Nobukazu Fujimoto, et al.. (2014). Phrenic Nerve Paralysis as the Initial Presentation in Pleural Sarcomatoid Mesothelioma. Case Reports in Oncology. 7(2). 389–392. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact